Phenindamine

Phenindamine

Clinical data
AHFS/Drugs.com	Micromedex Detailed Consumer Information
Pregnancy category	US: N (Not classified yet)
ATC code	R06AX04 (WHO)
Legal status
Legal status	US: OTC
Identifiers
IUPAC name 2-methyl-9-phenyl-2,3,4,9-tetrahydro-1H-indeno[2,1-c]pyridine
CAS Number	82-88-2 Y
PubChem CID	11291
DrugBank	DB01619 N
ChemSpider	10817 N
UNII	772BQ8KSST
KEGG	D08353 Y
ChEMBL	ChEMBL278398 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C19H19N
Molar mass	261.361 g/mol
3D model (JSmol)	Interactive image
SMILES CN(C1)CCC2=C1C(C3=C2C=CC=C3)C4=CC=CC=C4
InChI InChI=1S/C19H19N/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14/h2-10,19H,11-13H2,1H3 N Key:ISFHAYSTHMVOJR-UHFFFAOYSA-N N
NY (what is this?)  (verify)

WikiDoc Resources for Phenindamine
Articles
Most recent articles on Phenindamine Most cited articles on Phenindamine Review articles on Phenindamine Articles on Phenindamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Phenindamine Images of Phenindamine Photos of Phenindamine Podcasts & MP3s on Phenindamine Videos on Phenindamine
Evidence Based Medicine
Cochrane Collaboration on Phenindamine Bandolier on Phenindamine TRIP on Phenindamine
Clinical Trials
Ongoing Trials on Phenindamine at Clinical Trials.gov Trial results on Phenindamine Clinical Trials on Phenindamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Phenindamine NICE Guidance on Phenindamine NHS PRODIGY Guidance FDA on Phenindamine CDC on Phenindamine
Books
Books on Phenindamine
News
Phenindamine in the news Be alerted to news on Phenindamine News trends on Phenindamine
Commentary
Blogs on Phenindamine
Definitions
Definitions of Phenindamine
Patient Resources / Community
Patient resources on Phenindamine Discussion groups on Phenindamine Patient Handouts on Phenindamine Directions to Hospitals Treating Phenindamine Risk calculators and risk factors for Phenindamine
Healthcare Provider Resources
Symptoms of Phenindamine Causes & Risk Factors for Phenindamine Diagnostic studies for Phenindamine Treatment of Phenindamine
Continuing Medical Education (CME)
CME Programs on Phenindamine
International
Phenindamine en Espanol Phenindamine en Francais
Business
Phenindamine in the Marketplace Patents on Phenindamine
Experimental / Informatics
List of terms related to Phenindamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Phenindamine (Nolahist, Thephorin) is an antihistamine and anticholinergic closely related to cyproheptadine. It was developed by Hoffman-La Roche in the late 1940s. It is used to treat symptoms of the common cold and allergies, such as sneezing, itching, rashes, and hives. Its efficacy against some symptoms of opioid withdrawal was researched in the 1950s and 1960s in a number of countries; William S. Burroughs' book Junkie mentions this technique. Like many other first-generation antihistamines, phenindamine has useful potentiating effects on many narcotic analgesics and is even more useful with those opioids which release histamine when in the body.

Nolahist was originally manufactured in the USA by Carnrick Laboratories, and later by Amarin Pharmaceuticals. When that company ceased its American operations, its product line was acquired by Valeant, but they declined to resume manufacturing Nolahist. The last produced lot bore an expiration date of 10/2005, and the product is no longer available.

See also

• Cyproheptadine